UnitedHealth’s stock dropped over 6% on Wednesday following a report that the company secretly paid nursing homes to minimize hospital transfers, adding to the challenges faced by the healthcare giant. The practice, which was part of a broader strategy to cut costs, saved the company millions but, according to an investigation, sometimes jeopardized the health of residents.

These latest allegations are part of a series of setbacks for UnitedHealth, which has recently dealt with a major cyberattack at its Change Healthcare division, ongoing criminal and civil investigations into various practices (including Medicare fraud), and the sudden departure of CEO Andrew Witty last week. The company’s shares have fallen more than 39% this year, while the Dow saw only a slight decline of 0.6%.

In response to the report, UnitedHealth stated that the U.S. Department of Justice had investigated the matter, interviewing witnesses and reviewing thousands of documents, which revealed significant inaccuracies in the claims. The company also noted that the DOJ decided not to pursue the issue after its thorough investigation.

Despite this, the negative news continues to pile up for UnitedHealth. Sahak Manuelian, managing director of global equity trading at Wedbush, commented that it’s a challenging situation for investors to feel confident about putting their money in the company at this point.

Meanwhile, HSBC downgraded the stock from “hold” to “reduce” and lowered its price target to $270, citing concerns over rising medical costs, drug pricing pressures, the performance of its OptumRx pharmacy unit, and the possibility of Medicaid funding cuts that could hinder the company’s recovery.

In an attempt to navigate these challenges, UnitedHealth is relying on the return of Stephen Hemsley as CEO. James Harlow, senior vice president at Novare Capital Management, expressed confidence in Hemsley’s ability to restore the company’s credibility and help it recover from its current difficulties.